Efficacy of bazedoxifene for the prevention of postmenopausal osteoporosis: Results of a 2-year, phase III, placebo- and active-controlled study

被引：0

作者：

Kendler, D. L. ^{[1
]}

Miller, P. D. ^{[2
]}

Christiansen, C. ^{[3
]}

Hoeck, H. C. ^{[3
]}

Adachi, J. D. ^{[4
]}

Lewiecki, E. M. ^{[5
]}

Woodson, G. ^{[6
]}

Ciesielska, M. ^{[7
]}

Chines, A. A. ^{[7
]}

Constantine, G. ^{[7
]}

Delmas, P. D. ^{[8
,9
]}

机构：

[1] Osteoporosis Res Ctr, Vancouver, BC, Canada

[2] Univ Colorado, Med Ctr, Denver, CO 80202 USA

[3] Ctr Clin & Basic Res, Ballerup, Denmark

[4] McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada

[5] New Mexico Clin Res & Osteoporosis Ctr Inc, Albuquerque, NM USA

[6] Atlanta Res Ctr, Decatur, GA USA

[7] Wyeth Pharmaceut, Collegeville, PA USA

[8] Univ Lyon, Lyon, France

[9] INSERM, Res Unit 831, Lyon, France

来源：

JOURNAL OF RHEUMATOLOGY | 2008年 / 35卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1189 / 1189

页数：1

共 50 条

[21] Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study
Hale, ME
Dvergsten, C
Gimbel, J
JOURNAL OF PAIN, 2005, 6 (01): : 21 - 28
[22] Effects of bazedoxifene on BMD and bone turnover postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study (vol 23, pg 525, 2008)
Miller, P. D.
Chines, A. A.
Christiansen, C.
Hoeck, H. C.
Kendler, D. L.
Lewiecki, E. M.
Woodson, G.
Levine, A. B.
Constantine, G.
Delmas, P. D.
JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (05) : 773 - 774
[23] Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial
de Villiers, T. J.
Chines, A. A.
Palacios, S.
Lips, P.
Sawicki, A. Z.
Levine, A. B.
Codreanu, C.
Kelepouris, N.
Brown, J. P.
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (02) : 567 - 576
[24] Safety and Tolerability of Bazedoxifene in Postmenopausal Women With Osteoporosis: Results of a 5-year, Randomized, Placebo-controlled Phase 3 Trial
de Villiers, T.
Kendler, D.
Chines, A.
Lips, P.
Kaufman, J.
Levine, A.
Mairon, N.
Codreanu, C.
Felsenberg, D.
Brown, J.
BONE, 2010, 46 : S21 - S21
[25] SAFETY AND TOLERABILITY OF BAZEDOXIFENE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS OF A 5-YEAR, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
Kendler, D. L.
Chines, A. A.
Lips, P.
Kaufman, J. M.
Levine, A. B.
Mairon, N.
Codreanu, C.
Felsenberg, D.
Brown, J. P.
De Villiers, T. J.
OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 339 - 340
[26] Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial
T. J. de Villiers
A. A. Chines
S. Palacios
P. Lips
A. Z. Sawicki
A. B. Levine
C. Codreanu
N. Kelepouris
J. P. Brown
Osteoporosis International, 2011, 22 : 567 - 576
[27] Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study
Therese F. Nielsen
Pernille Ravn
Yu Z. Bagger
Lise Warming
Claus Christiansen
Osteoporosis International, 2004, 15 : 168 - 174
[28] Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study
Nielsen, TF
Ravn, P
Bagger, YZ
Warming, L
Christiansen, C
OSTEOPOROSIS INTERNATIONAL, 2004, 15 (02) : 168 - 174
[29] Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms
Bouchard, P.
Panay, N.
de Villiers, T. J.
Vincendon, P.
Bao, W.
Cheng, R. J.
Constantine, G.
CLIMACTERIC, 2012, 15 (01) : 12 - 20
[30] Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
Buynak, Robert
Shapiro, Douglas Y.
Okamoto, Akiko
Van Hove, Ilse
Rauschkolb, Christine
Steup, Achim
Lange, Bernd
Lange, Claudia
Etropolski, Mila
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (11) : 1787 - 1804

← 1 2 3 4 5 →